Application 218494
- Type
- ANDA
- Sponsor
- ZHEJIANG POLY PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BRIVARACETAM | BRIVARACETAM | SOLUTION;ORAL | 10MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218494-001 | BRIVARACETAM | BRIVARACETAM | 10MG/ML | SOLUTION / ORAL | AA | 2026-02-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218494-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218494-001 | BRIVARACETAM | 10MG/ML | SOLUTION / ORAL | AA | 2026-02-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218494-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| brivaracetam | BRIVARACETAM | Zhejiang Poly Pharm. Co., Ltd. | aef3ee92-e2a6-4135-94b2-b893f893d5f2 | 2026-02-23 | Warnings, Adverse reactions | 218494 ANDA218494 |
| Brivaracetam | BRIVARACETAM | PAI Holdings, LLC dba PAI Pharma | 57627ea9-3b14-4428-ad95-6ea25ecaef31 | 2026-02-03 | Warnings, Adverse reactions | 218494 ANDA218494 |